[
  {
    "criterion": "Provides incorrect information about the need for prophylaxis in immunosuppressed patients with latent TB",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Does not provide information about the treatment duration for isoniazid daily prophylaxis",
    "axis": "completeness",
    "point": -4
  },
  {
    "criterion": "Uses natural language and correct interpretation, responding to the user's follow-up question about a drug-resistant TB strain",
    "axis": "communication_quality",
    "point": 6
  },
  {
    "criterion": "Fails to advise seeking medical consultation for patients with a history of TB exposure or previous TB treatment",
    "axis": "completeness",
    "point": -5
  },
  {
    "criterion": "Correctly indicates that prophylaxis should be started before immunosuppressive therapy",
    "axis": "accuracy",
    "point": 8
  },
  {
    "criterion": "Does not provide information about potential side effects of isoniazid or rifapentine",
    "axis": "completeness",
    "point": -3
  },
  {
    "criterion": "Provides a clear and concise explanation of the treatment options for prophylaxis",
    "axis": "communication_quality",
    "point": 5
  },
  {
    "criterion": "Does not mention the importance of regular monitoring and follow-up during prophylaxis treatment",
    "axis": "completeness",
    "point": -2
  }
]